" class="no-js "lang="en-US"> Cancer Research UK Archives - Medtech Alert
Friday, December 01, 2023

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

High Street Pharmacies Spot Cancers In New NHS Early Diagnosis Drive

Staff in high street pharmacies will be funded to spot signs of cancer as part […]

One Million Checks Delivered By NHS ‘One Stop Shops’

NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]

Aromatase Inhibitors Cut Breast Cancer Recurrence in Younger Patients

Drugs called aromatase inhibitors reduce the risk of breast cancer returning by compared with oestrogen […]

New Breast and Lung Cancer Treatments Approved in Scotland

3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for […]

Targeted Drug Recommended to Treat Some Advanced Lung Cancer Patients

The National Institute for Health and Care Excellence (NICE) has recommended the use of selpercatinib (Retevmo) for […]

Immunotherapy Approved for Some People with Oesophageal Cancer on NHS in England

The National Institute for Health and Care Excellence (NICE) has recommended the use of the […]

New Chemotherapy-free Treatment for Bowel Cancer Made Available in Scotland

The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug pembrolizumab (Keytruda) for some adults with bowel cancer that’s […]

New Drug Combo for Advanced Breast Cancer Approved for NHS in England

The National Institute of Health and Care Excellence (NICE) has approved the use of a […]

New Option to Treat Advanced Oesophageal Cancer Approved for NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for patients with a type […]

First Treatment Approved in England for Advanced Bile Duct Cancer

The drug pemigatinib (Pemazyre) will now be an option for people with a rare type of bile […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more